[go: up one dir, main page]

NL301244I1 - Mycoplasma bovis stam N2805-1 - Google Patents

Mycoplasma bovis stam N2805-1

Info

Publication number
NL301244I1
NL301244I1 NL301244C NL301244C NL301244I1 NL 301244 I1 NL301244 I1 NL 301244I1 NL 301244 C NL301244 C NL 301244C NL 301244 C NL301244 C NL 301244C NL 301244 I1 NL301244 I1 NL 301244I1
Authority
NL
Netherlands
Prior art keywords
mycoplasma bovis
bovis strain
strain
mycoplasma
bovis
Prior art date
Application number
NL301244C
Other languages
English (en)
Other versions
NL301244I2 (nl
Original Assignee
Zoetis Services Llc
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc, Univ Melbourne filed Critical Zoetis Services Llc
Publication of NL301244I1 publication Critical patent/NL301244I1/nl
Publication of NL301244I2 publication Critical patent/NL301244I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NL301244C 2015-08-14 2023-09-29 Mycoplasma bovis stam N2805-1 NL301244I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205125P 2015-08-14 2015-08-14
PCT/US2016/046572 WO2017030901A1 (en) 2015-08-14 2016-08-11 Mycoplasma bovis compositions

Publications (2)

Publication Number Publication Date
NL301244I1 true NL301244I1 (nl) 2023-10-04
NL301244I2 NL301244I2 (nl) 2023-11-01

Family

ID=56800367

Family Applications (1)

Application Number Title Priority Date Filing Date
NL301244C NL301244I2 (nl) 2015-08-14 2023-09-29 Mycoplasma bovis stam N2805-1

Country Status (22)

Country Link
US (2) US11389518B2 (nl)
EP (2) EP3334454B1 (nl)
JP (1) JP6675484B2 (nl)
CN (3) CN115141772A (nl)
AU (2) AU2016307935B2 (nl)
BR (1) BR112018002919B1 (nl)
CA (1) CA2995101A1 (nl)
CY (2) CY1125699T1 (nl)
DK (1) DK3334454T3 (nl)
ES (1) ES2933623T3 (nl)
FI (1) FI3334454T3 (nl)
FR (1) FR23C1037I2 (nl)
HR (1) HRP20221440T1 (nl)
HU (2) HUE060545T2 (nl)
LT (1) LT3334454T (nl)
MX (1) MX389685B (nl)
NL (1) NL301244I2 (nl)
PL (1) PL3334454T3 (nl)
PT (1) PT3334454T (nl)
SI (1) SI3334454T1 (nl)
WO (1) WO2017030901A1 (nl)
ZA (1) ZA201800956B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN111471695A (zh) * 2020-05-11 2020-07-31 吉林农业大学 牛支原体免疫磁珠的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
EP0575491B1 (en) 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
IL101715A (en) 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
WO1993013302A1 (de) 1991-12-23 1993-07-08 Michael Zoche Motor mit einer vorrichtung zur entölung
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
JP2000507092A (ja) 1996-02-28 2000-06-13 バイエル・アクチエンゲゼルシヤフト 外来ｄｎａを含むパラポックスウイルス、それらの製造及びワクチンにおけるそれらの使用
BR9712852A (pt) 1996-10-23 1999-11-16 Univ Pennsylvania Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
BR9908267A (pt) 1998-02-27 2000-10-24 Univ Pennsylvania Plasmìdeo, composição farmacêutica, processos para induzir uma resposta imunológica em um indivìduo contra um imunógeno, para imunizar um indivìduo contra uma infecção por vìrus de herpes simples e para tratar um indivìduo que tem uma doença autoimune, vacina recombinante, e, patógeno atenuado vivo
JP2002506048A (ja) 1998-03-13 2002-02-26 アメリカン・ホーム・プロダクツ・コーポレーション ポリヌクレオチド組成物、その製造方法および使用
MXPA01003228A (es) 1998-09-30 2003-06-24 American Cyanamid Co Holotoxina de colera mutante como un coadyuvante.
MXPA02004627A (es) 1999-11-08 2004-02-18 Biomune Vacunas contra el micoplasma bovis y sus metodos de uso.
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
GB0110851D0 (en) 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
EP1404368B1 (en) 2001-06-07 2009-12-09 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
CA2449670A1 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
US7638134B2 (en) 2003-02-20 2009-12-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Insertion sites in fowlpox vectors
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
EP2320943B1 (en) 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
WO2010051210A1 (en) * 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
JP5753098B2 (ja) * 2009-02-20 2015-07-22 オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド 弱毒生ワクチン
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
MX389685B (es) 2025-03-20
CN115141773A (zh) 2022-10-04
LT3334454T (lt) 2022-12-27
FR23C1037I1 (fr) 2023-12-08
JP2018523708A (ja) 2018-08-23
PT3334454T (pt) 2022-12-20
BR112018002919B1 (pt) 2024-02-27
CY1125699T1 (el) 2024-02-16
US20190255166A1 (en) 2019-08-22
NL301244I2 (nl) 2023-11-01
NZ739767A (en) 2025-05-02
AU2016307935A1 (en) 2018-02-22
NZ778923A (en) 2025-05-02
FR23C1037I2 (fr) 2025-12-19
HK1251478A1 (en) 2019-02-01
HUE060545T2 (hu) 2023-03-28
AU2022231761A1 (en) 2022-10-06
CN108135989B (zh) 2022-08-09
HRP20221440T1 (hr) 2023-02-03
PL3334454T3 (pl) 2023-01-30
BR112018002919A2 (pt) 2018-09-18
CY2023020I1 (el) 2024-02-16
CN108135989A (zh) 2018-06-08
EP4137152A1 (en) 2023-02-22
CY2023020I2 (el) 2024-02-16
CN115141772A (zh) 2022-10-04
EP3334454A1 (en) 2018-06-20
ZA201800956B (en) 2018-12-19
AU2016307935B2 (en) 2022-08-18
DK3334454T3 (da) 2022-11-14
US11389518B2 (en) 2022-07-19
WO2017030901A1 (en) 2017-02-23
JP6675484B2 (ja) 2020-04-01
AU2022231761B2 (en) 2025-09-18
US20220296694A1 (en) 2022-09-22
MX2018001841A (es) 2018-08-01
HUS2300032I1 (hu) 2024-07-28
FI3334454T3 (fi) 2023-01-13
EP3334454B1 (en) 2022-10-19
CA2995101A1 (en) 2017-02-23
SI3334454T1 (sl) 2023-02-28
ES2933623T3 (es) 2023-02-10

Similar Documents

Publication Publication Date Title
PL3345230T3 (pl) Podwójny perowskit
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
DK3140314T3 (da) Kaloriefrit sødestof
EP3388526A4 (en) MICRO BACTERIA
DK2952752T3 (da) Afbøjnings-rørbøjning
EP3521414A4 (en) XYLARIA GRAMMICA
ME03312B (me) Vorтiokseтin piroglutamat
HRP20200170T1 (hr) Celobioza fosforilaza
NL301244I2 (nl) Mycoplasma bovis stam N2805-1
DE112015002630A5 (de) Rollenelement
DK3057373T3 (da) Enkeltcelle-punkt-til-multipunkt-overførsel
EP3476930A4 (en) Pseudozyma
DK3307076T3 (da) Podepartikelprodukt
DE112016003063A5 (de) Verstellvorrichtung
EP3171776C0 (de) Abbildungsanordnung
EP3468815A4 (en) SPACER
DK3265233T5 (da) Vertikal-valsemølle
ITUB20153989A1 (it) Marcatrice
FI11464U1 (fi) Vedonpoistaja
ITUB20153732A1 (it) Macchina piegafogli
FI20165399A7 (fi) Vedonpoistaja
FI11157U1 (fi) Painotelalaite
TH1601007022A (th) ผลิตภัณฑ์สวมใส่
FI11045U1 (fi) Konerulla
TWD174411S (zh) 文件夾